Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The future of sickle cell disease therapeutics rests in genomics. | Dis Model Mech | 2023 | 36815490 | PubTator, text mining | PubMed |
| Discovery of a biomarker for β-Thalassemia by HPLC-MS and improvement from Proton Transfer Reaction - Parallel Ion Parking. | J Mass Spectrom Adv Clin Lab | 2023 | 36814695 | PubTator, text mining | PubMed |
| Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell. | Cell Death Dis | 2023 | 36805688 | PubTator, text mining | PubMed |
| Genetics of migraine: where are we now? | J Headache Pain | 2023 | 36800925 | PubTator, text mining | PubMed |
| The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies. | Mol Genet Genomic Med | 2023 | 36785910 | PubTator, text mining | PubMed |
| Atomic force microscopy reveals involvement of the cell envelope in biomechanical properties of sickle erythrocytes. | BMC Biol | 2023 | 36782158 | PubTator, text mining | PubMed |
| Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies. | Eur J Hum Genet | 2023 | 36781956 | PubTator, text mining | PubMed |
| Tramadol as a Voltage-Gated Sodium Channel Blocker of Peripheral Sodium Channels Nav1.7 and Nav1.5. | Biomol Ther (Seoul) | 2023 | 36779240 | PubTator, text mining | PubMed |
Compound Heterogeneous Sickle Cell-B+ Thalassemia Incidentally Discovered Through Cytological Examination of a Fine-Needle Aspiration Specimen from an Aneurysmal Bone Cyst in a Young Child: A Case Report. | Cureus | 2023 | 36779144 | PubTator, text mining | PubMed |
| PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers. | Epilepsia Open | 2023 | 36775847 | PubTator, text mining | PubMed |
| Polymorphisms Affecting the Response to Novel Antiepileptic Drugs. | Int J Mol Sci | 2023 | 36768858 | PubTator, text mining | PubMed |
| Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases. | Int J Mol Sci | 2023 | 36768323 | PubTator, text mining | PubMed |
| Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. | Int J Mol Sci | 2023 | 36768153 | PubTator, text mining | PubMed |
| Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. | Cancers (Basel) | 2023 | 36765727 | PubTator, text mining | PubMed |
| The current landscape of epilepsy genetics: where are we, and where are we going? | Curr Opin Neurol | 2023 | 36762645 | PubTator, text mining | PubMed |
| Genetic and environmental risk factors of acute infection-triggered encephalopathy. | Front Neurosci | 2023 | 36761411 | PubTator, text mining | PubMed |
| Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies. | Neurology | 2023 | 36750385 | PubTator, text mining | PubMed |
| Perampanel as precision therapy in rare genetic epilepsies. | Epilepsia | 2023 | 36734057 | PubTator, text mining | PubMed |
| A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. | Comput Struct Biotechnol J | 2023 | 36733702 | PubTator, text mining | PubMed |
| A novel SLC20A2 mutation presenting with paroxysmal kinesigenic dyskinesia and epilepsy in a Chinese patient: a case report. | Acta Neurol Belg | 2023 | 36701080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=28